(1) Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

(1) Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands; (2) Immunohematology and Transfusion Medicine Department, Ospedali Riuniti di Bergamo, Bergamo, Italy; (3) Department of Hematology, Academical Medical Center, University of Amsterdam, Amsterdam, The Netherlands; (4) Present address: Department of Hematology, Academic Medical Center, University of Utrecht, Utrecht, The Netherlands; (5) Pressent address: Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands. 6Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; (6) Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands

(1) Hematological research group (HERG), Department of Clinical Medicine, University of Tromsø, Norway; (2) Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

(1) Department of Endocrinology, Hippokration Hospital, Thessaloniki, Greece; (2) Division of Haematology, 2nd Propedeutic Department of Internal Medicine, Aristotle University, Hippokration Hospital, Thessaloniki, Greece; (3) Department of biochemistry, Hormone Assay Laboratory, Hippokration Hospital, Thessaloniki, Greece; (4) Department of Psychology, School of Philosophy, Aristotle University, Thessaloniki, Greece; (5) Radiology Department, Hippokration Hospital, Thessaloniki, Greece; (6) 1st Department of Microbiology, Medical School, Aristotle University, Thessaloniki, Greece

(1) Walter-Brendel-Centre of Experimental Medicine, Ludwig-Maximilians-University, Munich, Germany; (2) Kerckhoff Clinic, Bad Nauheim, Germany; (3) Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany; (4) Department of Biochemistry, Justus-Liebig-University, Giessen, Germany; (5) Department of Animal Biology, Faculty of Science, University of Málaga, Málaga, Spain

(1) Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich, Germany; (2) Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany; (3) Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, the Netherlands; (4) Department of Vascular Surgery (J.G.), RWTH Aachen University, Aachen, Germany

(1) Etablissement Français du Sang-Alsace (EFS-Alsace), Strasbourg, France; (2) INSERM U949, Strasbourg, France; (3) UMR-S949, Université de Strasbourg, Strasbourg, France

(1) Deutsches Herzzentrum der Technischen Universität München, München, Germany.

(1) Department of Drug Management, Institute of Public Health, Collegium Medicum, Jagiellonian University, Krakow, Poland; (2) Department of Angiology, 2nd Chair of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, Poland

(1) Department of Physiology and Regenerative Medicine, Kinki University Faculty of Medicine, Osaka, Japan; (2) Department of Animal Bioscience, Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Shiga, Japan; (3) Life Science Research Institute, Kinki University, Osaka, Japan; (4) Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan

(1) Department of Neurology, Yonsei University College of Medicine, Seoul, Korea; (2) Department of Radiology, Yonsei University College of Medicine, Seoul, Korea; (3) Department of Neurology, Yonsei Wonju University College of Medicine, Wonju, Korea; (4) Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea

(1) Department of Pathology and Laboratory Medicine, Centre for Blood Research, University of British Columbia; Canadian Blood Services, Research and Development Department, Vancouver, British Columbia, Canada

(1) Rudolf-Virchow-Center/DFG-Research Center for Experimental Biomedicine, University of Würzburg, Germany

(1) Boston Health Economics, Inc., Waltham, Massachusetts, USA; (2) CSL Behring, King of Prussia, Pennsylvania, USA

(1) Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas, USA; (2) Institute of Cardiology, “G. d’Annunzio” University, Chieti, Italy; (3) Baylor College of Medicine, Houston, Texas, USA

(1) Division of Cardiovascular Sciences, Laboratory of Thrombosis and Haemostasis, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain

(1) Cardiovascular Medicine, University of Nottingham, Nottingham, UK

(1) Division of Hematology, Duke University Medical Center, Durham, North Carolina, USA; (2) Paringenix, Inc, Weston, Florida, USA; (3) Department of Civil and Environmental Engineering, Duke University Medical Center, Durham, North Carolina, USA; (4) The University of North Carolina, School of Pharmacy and School of Medicine, Chapel Hill, North Carolina, USA

(1) Biochemistry Center Regensburg (BZR), Laboratory for RNA Biology, University of Regensburg, Regensburg, Germany

(1) Departments of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands; (2) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK; (3) Department of Neurology, University Hospital Essen, Essen, Germany; (4) Global Clinical Development and Medical Affairs, Boehringer Ingelheim GmbH & Co. KG, Ingelheim, Germany; (5) Department of CardioMetabolic Disease Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany

(1) Université de Lyon, EA3065, Université Jean Monnet, Saint-Etienne, France; (2) Inserm, CIE3, Saint-Etienne, France; (3) URCIP, CHU Saint-Etienne, Hôpital Nord, Saint-Etienne, France; (4) Department of Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland; (5) EA2992, Faculté de Médecine et Université de Montpellier-Nîmes, Nîmes, France; (6) Division of Angiology and Haemostasis, Faculty of Medicine and University Hospitals of Geneva, Geneva, Switzerland

(1) Department of Cardiologic, Thoracic and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua, Padua, Italy; (2) IRCCS Hemostasis and Thrombosis Unit & Department of Biomedical Sciences, University of Foggia, Foggia, Italy; (3) Department of Hematology, Catholic University, Rome, Italy; (4) Department of Hematology, San Bortolo Hospital, Vicenza, Italy; (5) Department of Angiology and Coagulation Disorders, University of Bologna, Italy

(1) Helios Klinikum Duisburg, St. Johannes Hospital, Medizinische Klinik 2, Duisburg, Germany; (2) Institut für Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universität Greifswald, Germany; (3) Institut für Humangenetik, Ernst-Moritz-Arndt Universität Greifswald, Germany

(1) Center for Human Genetics Research, Vanderbilt University, Nashville, Tennessee, USA; (2) Department of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, Tennessee, USA

(1) Research Center, La Fe University Hospital, Valencia, Spain; (2) Hemostasis and Thrombosis Unit, La Fe University Hospital, Valencia, Spain; (3) Centro Regional de Hemodonación, Universidad de Murcia, Spain; (4) Department of Thrombosis and Haemostasis, Leiden University Medical Centre, Leiden, The Netherlands

(1) Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, the Netherlands; (2) Division of Haemostasis and Thrombosis, Department of Haematology, University Medical Centre Groningen, University of Groningen, the Netherlands

(1) Department of Nephrology, Ghent University Hospital, Ghent, Belgium

(1) Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria; (2) 3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria; (3) Department of Obstetrics and Gynaecology, Wilhelminenhospital, Vienna, Austria; (4) Department of Laboratory Medicine, Wilhelminenhospital, Vienna, Austria; (5) Department of Cardiology, Medical University of Vienna, Vienna, Austria

(1) Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, Japan; (2) Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan; (3) Department of Obstetrics and Gynecology, Toyama University, Graduate School of Medical Sciences, Toyama, Japan; (4) Haemostasis Center, Universitätsklinikum Giessen und Marburg GmbH, Marburg, Germany; (5) Departments of Vascular Medicine and Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

(1) John Paul II Hospital, Krakow, Poland; (2) Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland

(1) Research Laboratories, Fondazione di Ricerca e Cura “Giovanni Paolo II”, Università Cattolica, Campobasso, Italy

(1) Cardiology Division, Foundation for Medical Research, Department of Medical Specialties, University of Geneva, Geneva, Switzerland; (2) Department of Chemistry, Montréal University, Montréal, Québec, Canada

(1) Australian Centre for Blood Diseases, Monash University, Alfred Medical Research & Education Precinct, Melbourne, Australia

(1) Marc and Ruti Bell Vascular Biology and Disease Program, New York University School of Medicine, New York, New York, USA; (2) Department of Medicine and Cell Biology, New York University School of Medicine, New York, New York, USA; (3) Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, New York, USA

(1) Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany; (2) Institute for Medical Biometry, Informatics and Epidemiology, University Clinic Bonn, Bonn, Germany; (3) Life and Medical Sciences Institute, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany

(1) Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Ontario, Canada

(1) Service d'hématologie biologique, Pôle Laboratoires, CHU Nancy, Nancy, France; (2) Service de réanimation médicale, Pôle Urgences Réanimation Médicale, CHU Nancy, Nancy, France

(1) Institut fuer Klinische Biochemie und Pathobiochemie-Zentrallabor, Universitaetsklinikum Wuerzburg, Wuerzburg, Germany; (2) Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 194223 St. Petersburg, Russia

(1) Guy’s and St.Thomas’ NHS Foundation Trust, London, UK; (2) King’s College, London, UK

(1) Department of Medicine, Endocrinology, Metabolism and Geriatrics, University of Modena and Reggio Emilia, Modena, Italy; (2) Division of Biopharmaceutics, Gorlaeus Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, Leiden, The Netherlands; (3) Apogee Biotechnology Corporation, Hershey, Pennsylvania, USA; (4) Institute of Immunology, University of Münster, Münster, Germany; (5) Department of Anaesthesiology and Intensive Medicine, University Hospital Münster, Münster, Germany; (6) Leibniz-Institute for Arteriosclerosis Research, University of Münster, Münster, Germany; (7) Center for Laboratory Medicine, University Hospital Münster, Münster, Germany

(1) Department of Pediatrics, Fukuchiyama City Hospital, Fukuchiyama, Japan; (2) Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, Japan

(1) Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Sydney, Australia; (2) Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, Australia; (3) SEALS, Prince of Wales Hospital, Sydney, Australia; (4) Department of Haematology SA Pathology, Adelaide, Australia; (5) Department of Haematology, Royal Perth Hospital, Perth, Australia; (6) Monash Medical Centre, Melbourne, Australia; (7) Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia; (8) Royal Prince Alfred Hospital, Sydney, Australia; (9) Haematology Department, St Vincent Hospital, Sydney, Australia

(1) Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands; (2) Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; (3) Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, University of Leiden, Leiden, The Netherlands; (4) Department of Clinical Epidemiology, Leiden University Medical Center, University of Leiden, Leiden, The Netherlands; (5) Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

(1) Centro Regional de Hemodonación, University of Murcia, Spain; (2) Unidad de Hemostasia y Trombosis del Complejo Hospitalario Universitario, A Coruña, Spain; (3) Unitat d'Hemostàsia i Trombosi, Departament d'Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

(1) Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK; (2) Department of Cardiovascular Science, The University of Sheffield Medical School, UK

(1) The Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada; (2) Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; (3) Department of Medicine, McMaster University, Hamilton, Ontario, Canada; (4) Department of Hematology/Oncology, Centre Hospitalier Universitaire Sainte-Justine, McMaster University, Hamilton, Ontario, Canada

(1) Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Ontario, Canada

(1) Department of Internal Medicine III / Cardiology, Innsbruck Medical University, Austria; (2) Department of Cardiology, King´s College London, UK

(1) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK; (2) Department of Cardiology, Copenhagen University Hospital Gentofte, Denmark